Literature DB >> 16830240

[Palliative radiation of bone metastasis in the spine for symptom control and stabilisation: indication and limits].

Angelika Drobil-Unterberger1.   

Abstract

On the basis of a case study the success of palliative radiation of metastasis of a non-small-cell lung cancer in the spine is demonstrated and the limits of this palliative therapy are discussed. Pain control seems to be the first aim, stabilisation of the spine and myelodecompression to prevent paraplegia could be another.

Entities:  

Mesh：

Year:  2006        PMID： 16830240     DOI： 10.1007/s10354-006-0283-8

Source DB:  PubMed          Journal:  Wien Med Wochenschr        ISSN： 0043-5341


  6 in total

Review 1.  [Diagnosis and therapy of lung neoplasms. Interdisciplinary guidelines].

Authors: 
Journal:  Wien Klin Wochenschr       Date:  2005       Impact factor: 1.704

2.  Prognostic factors for patients with osseous metastasis: a multi-institutional prospective study.

Authors:  T Teshima; M Chatani; T Inoue; Y Hirokawa; K Wadasaki; K Kasiwado; M Kagemoto; S Katsuta; Y Honke; T Koyama
Journal:  Strahlenther Onkol       Date:  1990-06       Impact factor: 3.621

3.  A multicenter, randomized, phase III study of docetaxel plus best supportive care versus best supportive care in chemotherapy-naive patients with metastatic or non-resectable localized non-small cell lung cancer (NSCLC).

Authors:  K Roszkowski; A Pluzanska; M Krzakowski; A P Smith; E Saigi; U Aasebo; A Parisi; N Pham Tran; R Olivares; J Berille
Journal:  Lung Cancer       Date:  2000-03       Impact factor: 5.705

4.  A prospective randomised trial of 4 Gy or 8 Gy single doses in the treatment of metastatic bone pain.

Authors:  P J Hoskin; P Price; D Easton; J Regan; D Austin; S Palmer; J R Yarnold
Journal:  Radiother Oncol       Date:  1992-02       Impact factor: 6.280

Review 5.  Lung cancer in Europe in 2000: epidemiology, prevention, and early detection.

Authors:  Jerzy E Tyczynski; Freddie Bray; D Maxwell Parkin
Journal:  Lancet Oncol       Date:  2003-01       Impact factor: 41.316

6.  Clinical benefit from palliative chemotherapy in non-small-cell lung cancer extends to the elderly and those with poor prognostic factors.

Authors:  T F Hickish; I E Smith; M E O'Brien; S Ashley; G Middleton
Journal:  Br J Cancer       Date:  1998-07       Impact factor: 7.640
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.